Hydroxyurea Exposure Triggers Tissue-Specific Activation of p38 Mitogen-Activated Protein Kinase Signaling and the DNA Damage Response in Organogenesis-Stage Mouse Embryos

Hydroxyurea (HU) is commonly used to treat myeloproliferative diseases and sickle cell anemia. The administration of HU to gestation day 9 CD1 mice causes predominantly hindlimb, tail, and neural tube defects. HU induces oxidative stress and p38 mitogen-activated protein kinase (MAPK) signaling in e...

Descripción completa

Detalles Bibliográficos
Autores principales: Banh, Serena, Hales, Barbara F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663560/
https://www.ncbi.nlm.nih.gov/pubmed/23492809
http://dx.doi.org/10.1093/toxsci/kft069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663560/
https://www.ncbi.nlm.nih.gov/pubmed/23492809
http://dx.doi.org/10.1093/toxsci/kft069

Ejemplares similares